Brief: Euronext Paris Suspends Shares in Medincell At The Request Of The Company
May 8 (Reuters) - Medincell SA MEDCL.PA :
* ANNOUNCES SUSPENSION OF LISTING OF ITS SHARES ON EURONEXT
PARIS
* TRADING ON EURONEXT PARIS WILL RESUME TOMORROW AT OPENING
OF
MARKETS
Source text for Workspace: ID:nBw61nzN4a
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medincell SA
See all newsBrief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris